Hu Siyao, Zuo Huali, Qi Jin, Hu Yuanjia, Yu Boyang
Jiangsu Key Laboratory of Traditional Medicine and Translational Research, China Pharmaceutical University, Nanjing, China.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau.
Front Pharmacol. 2019 Mar 20;10:232. doi: 10.3389/fphar.2019.00232. eCollection 2019.
is a commonly used traditional Chinese medicine, which has been widely used in the treatment of acute myocardial infarction in China. However, it has been difficult to systematically clarify the major pharmacological effect of , due to its multi-component complex mechanism. In order to solve this problem, a comprehensive network analysis method was established based-on "component-gene ontology-effect" interactions. Through the network analysis, reduction of cardiac preload and myocardial contractility was shown to be the major effect of components, which was further experimentally validated. In addition, the expression of and in myocyte were experimentally confirmed to be associated with in the treatment of AMI, which may be responsible for the preservation effect of myocardial contractility. In conclusion, the three-mode gene ontology network can be an effective network analysis workflow to evaluate the pharmacological effects of a multi-drug complex system.
是一种常用的中药,在中国已广泛用于治疗急性心肌梗死。然而,由于其多成分复杂机制,一直难以系统阐明其主要药理作用。为了解决这个问题,基于“成分-基因本体-效应”相互作用建立了一种综合网络分析方法。通过网络分析,发现降低心脏前负荷和心肌收缩力是该成分的主要作用,并进一步通过实验验证。此外,实验证实心肌细胞中[具体基因1]和[具体基因2]的表达与治疗急性心肌梗死时的[药物名称]相关,这可能是其对心肌收缩力的保护作用的原因。总之,三模式基因本体网络可以成为评估多药复合系统药理作用的有效网络分析工作流程。